A Phase IV-Pharmacovigilance Study of Keppra Greece - S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy
Status:
Completed
Trial end date:
2004-07-01
Target enrollment:
Participant gender:
Summary
Patients in community-based practices correspond to the 25% of patients who need a first
add-on drug when not controlled by their standard monotherapy drug. This was a therapeutic
use trial in which the population corresponds more closely to that seen in daily clinical
practice.